Clinical Trials
6 trialsNCT03651206 2026-06-01
ROCSAN
ARCAGY/ GINECO GROUP
Phase 2/3 Recruiting
NCT05819892 2026-05-29
Phase I Trial Testing the Safety and Tolerability of Chemoradiation Followed by Chemotherapy + Dostarlimab for Stage IIIC, Node Positive, Endometrial Cancer
M.D. Anderson Cancer Center
Phase 1 Recruiting
NCT06256588 2026-05-26
JADE
GlaxoSmithKline
Phase 3 Recruiting
NCT06551142 2026-05-22
PanTumor-101
GlaxoSmithKline
Phase 1 Recruiting
NCT06567782 2026-05-22
AZUR-4
GlaxoSmithKline
Phase 2 Recruiting
NCT06796907 2026-05-22
BEHOLD-2
GlaxoSmithKline
Phase 1/2 Recruiting